World Malaria Day – 25th April

Did you know that the 25th April is World Malaria Day? Over 15 countries are still at potential risk from malaria, and last year saw 200 million cases of the mosquito bourne disease which resulted in 500,000 deaths. BBI is commited to providing biological raw materials for use in the detection and early diagnosis of […]

Purity check close up

BBI Solutions launches a new recombinant human antigen; Galectin-3

We are pleased to announced the launch of a new antigen: recombinant Galectin-3 (Gal-3) to BBI’s portfolio.  A multi-function marker which aids with the assessment and diagnosis of chronic heart failure as well as various cancer types. Galectin-3 belongs to the lectin family and is a carbohydrate binding antigen. It is predominantly expressed in the […]

Biomarkers congress

Back to the future for Biomarkers

It’s an exciting time to be in the Biomarkers industry, with advances far surpassing anything we could have dreamed of in the 80’s. Our very own Doc.. Simon Packer attended the 11th Biomarkers Congress in Manchester where leading experts in the industry and academia come together to present advances in biomarker discovery. The congress was set […]


BBI out and about

Only 3 months into 2016 and we’re already preparing for our 3rd trade show in Asia! It’s been a busy first quarter for our hard working BBI team. Arab Health 2016 in Dubai saw us speaking to a number of potential distributors, interested in representing BBI in regions we have not yet expanded into.  It […]